202 related articles for article (PubMed ID: 35456981)
1. Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid.
Fernandes MF; Tomczewski MV; Duncan RE
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456981
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Gintonin-Enriched Fraction on Glucagon-Like-Protein-1 Release.
Lee R; Choi SH; Cho HS; Hwang H; Rhim H; Kim HC; Hwang SH; Nah SY
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684879
[TBL] [Abstract][Full Text] [Related]
3. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-4 and GLP-1 interplay in STC-1 and GLUTag cell lines.
Kamakura R; Raza GS; Prasannan A; Walkowiak J; Herzig KH
Peptides; 2020 Dec; 134():170419. PubMed ID: 32998057
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
7. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
[TBL] [Abstract][Full Text] [Related]
10. Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy.
Simo KA; Niemeyer DJ; Hanna EM; Swet JH; Thompson KJ; Sindram D; Iannitti DA; Eheim AL; Sokolov E; Zuckerman V; McKillop IH
HPB (Oxford); 2014 Jun; 16(6):534-42. PubMed ID: 24750398
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells.
Dietze R; Starzinski-Powitz A; Scheiner-Bobis G; Tinneberg HR; Meinhold-Heerlein I; Konrad L
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1369-1377. PubMed ID: 30591146
[TBL] [Abstract][Full Text] [Related]
13. Chylomicrons stimulate incretin secretion in mouse and human cells.
Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells.
Chou CH; Lai SL; Ho CM; Lin WH; Chen CN; Lee PH; Peng FC; Kuo SH; Wu SY; Lai HS
PLoS One; 2015; 10(3):e0122060. PubMed ID: 25822713
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells.
Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T
J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434
[TBL] [Abstract][Full Text] [Related]
16. Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells.
McDonald WS; Miyamoto K; Rivera R; Kennedy G; Almeida BSV; Kingsbury MA; Chun J
Mol Brain; 2020 Dec; 13(1):169. PubMed ID: 33317583
[TBL] [Abstract][Full Text] [Related]
17. The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway.
Kato M; Tani T; Terahara N; Tsuda T
PLoS One; 2015; 10(5):e0126157. PubMed ID: 25962102
[TBL] [Abstract][Full Text] [Related]
18. OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.
Nsaibia MJ; Boulanger MC; Bouchareb R; Mkannez G; Le Quang K; Hadji F; Argaud D; Dahou A; Bossé Y; Koschinsky ML; Pibarot P; Arsenault BJ; Marette A; Mathieu P
Cardiovasc Res; 2017 Sep; 113(11):1351-1363. PubMed ID: 28472283
[TBL] [Abstract][Full Text] [Related]
19. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor.
Diakogiannaki E; Pais R; Tolhurst G; Parker HE; Horscroft J; Rauscher B; Zietek T; Daniel H; Gribble FM; Reimann F
Diabetologia; 2013 Dec; 56(12):2688-96. PubMed ID: 24045836
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid (LPA) receptor-mediated signaling regulates hypoxia-induced biological functions of lymphatic endothelial cells.
Yamamoto M; Takai M; Yashiro N; Hayasaka H; Tsujiuchi T
Biochem Biophys Res Commun; 2024 Jun; 715():149982. PubMed ID: 38676998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
